Sign Out
Instruction for Use and Handling: The withdrawn amount of concentrate must be further diluted in 100 mL of sterile 0.9% w/v sodium chloride solution or 5% w/v glucose solution. The dose must be given as a single intravenous infusion over no less than 15 minutes.
Patients must be maintained well hydrated prior to and following administration of OLEDRON.
Aseptic techniques must be followed during the preparation of the infusion. For single use only.
Only clear solution free from particles and discoloration should be used.
Any unused medicinal product or waste material should be disposed of in accordance with local requirements.
Incompatibilities: OLEDRON must not be mixed with calcium or other divalent cation- containing infusion solutions such as lactated Ringer's solution, and should be administered as a single intravenous solution in a separate infusion line.
Patients must be maintained well hydrated prior to and following administration of OLEDRON.
